Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial
- 9 August 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 13 (4) , 488-497
Abstract
Opioid use disorder (OUD) is a chronic, relapsing condition with severe negative health consequences. Previous studies have reported that 5-year opioid abstinence is a good predictor of reduced likelihoods of relapse, but factors that shape long-term opioid abstinence are poorly understood. The present study is based on data from a prospective study of 699 adults with OUD who had been randomized to either methadone or buprenorphine/naloxone and who were followed for at least 5 years. During the 5 years prior to the participants’ last follow-up interview, 232 (33.2%) had achieved 5-year abstinence from heroin. Of those 232, 145 (20.7% of the total) had remained abstinent from both heroin and other opioids (e.g., hydrocodone, oxycodone, other opioid analgesics, excluding methadone or buprenorphine). Compared to non-abstinent individuals, those in both categories of opioid abstinence had lower problem severity in health and social functioning at the final follow-up. Logistic regression results indicated that cocaine users and injection drug users were less likely to achieve 5-year heroin abstinence, whereas Hispanics (vs. whites) and those treated in clinics on the West Coast (vs. East) were less likely to achieve 5-year abstinence from heroin and other opioids. For both abstinence category groups, abstinence was positively associated with older age at first opioid use, lower impulsivity, longer duration of treatment for OUD, and greater social support. Reducing cocaine use and injection drug use and increasing social support and retention in treatment may help maintain long-term abstinence from opioids among individuals treated with agonist pharmacotherapy.Keywords
Funding Information
- National Institute on Drug Abuse (U10 DA01714, U10 DA 015815, U10 DA13038, U10 DA13043, U10 DA13045, UG1 DA013035)
This publication has 45 references indexed in Scilit:
- Predictors of heroin relapse: Personality traits, impulsivity, COMT gene Val158met polymorphism in a 5‐year prospective study in Shanghai, ChinaAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2015
- Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment StudyDrug and Alcohol Dependence, 2015
- Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite studyDrug and Alcohol Dependence, 2013
- Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trialDrug and Alcohol Dependence, 2013
- Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: A naturalistic study in 2694 patientsDrug and Alcohol Dependence, 2008
- Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS)Addictive Behaviors, 2007
- Improving drug treatment services for hispanics: Research gaps and scientific opportunitiesDrug and Alcohol Dependence, 2006
- A 33-Year Follow-up of Narcotics AddictsArchives of General Psychiatry, 2001
- Timeline Follow-Back1992
- The fifth edition of the addiction severity indexJournal of Substance Abuse Treatment, 1992